Rectal Biopsy

PROCEDURE5 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Herlev Hospital, National Cancer Institute (NCI), Universitaire Ziekenhuizen KU Leuven, Royal Brompton & Harefield NHS Foundation Trust

Conditions

CFTR-related DisordersColorectal AdenomaColorectal CarcinomaCystic FibrosisCystic Fibrosis (CF)HIV InfectionsHIV SeronegativitySeptic Shock

Phase 2

Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma

Active, not recruitingNCT02965703

National Cancer Institute (NCI)Colorectal Adenoma, Colorectal Carcinoma

Start: 2018-01-16End: 2026-12-24Updated: 2026-04-03

Unknown Phase

A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials

CompletedNCT00075062

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, HIV Seronegativity

Target: 16Updated: 2008-08-21

Barrier Function and Production of Inflammatory Cytokines in the Rectal Mucosa in Patients With Septic Shock

Herlev HospitalSeptic Shock

Start: 2010-01-31Target: 30Updated: 2009-06-23

Organoid Study R334W

WithdrawnNCT04254705

Universitaire Ziekenhuizen KU LeuvenCystic Fibrosis

Start: 2020-03-01End: 2021-03-01Updated: 2023-04-18

A Prospective Study of Advanced Diagnostics in People With an Unclear Diagnosis of Cystic Fibrosis

Not yet recruitingNCT07402434

Royal Brompton & Harefield NHS Foundation TrustCFTR-related Disorders, Cystic Fibrosis (CF)

Start: 2026-02-02End: 2028-09-01Target: 80Updated: 2026-02-17

Related Papers

Evaluating intermittent dosing of aspirin for colorectal cancer prevention.

Journal of Clinical Oncology2018-05-202 citations